Pfizer’s second quarter results were well received by the market, as the company outperformed Wall Street’s expectations for ...

As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...

Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...

Pfizer (PFE) topped second quarter expectations, but looming Trump-era pharmaceutical tariffs remain a concern. Pfizer CEO ...

Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...

Pfizer's Albert Bourla told investors that major drugmakers are "ready to roll up their sleeves" and build out more direct-to ...

The biotech industry needs to be supported by the government, by Congress,” Pfizer’s Albert Bourla told investors Tuesday in ...

Albert Bourla confirmed that he called President Donald Trump after receiving a letter asking Pfizer and a clutch of other ...

User Clip: Pfizer CEO Dr. Albert Bourla got booed by the crowd at the White House MP4 video - Standard Price: $4.99 or Free with MyC‑SPAN Request Download MP3 audio - Standard Price: $0.99 ...

Pfizer CEO Albert Bourla said on ABC's "This Week" Sunday it's possible to provide both COVID-19 booster shots as well as doses for people who have not yet been vaccinated.

It's not clear yet if one is needed. Bourla said Pfizer is also hoping to make a vaccine that will protect against Omicron and all other variants of SARS-CoV-2 -- the virus that causes Covid-19.